EP2592937A1 - Improved drying of components - Google Patents
Improved drying of componentsInfo
- Publication number
- EP2592937A1 EP2592937A1 EP11738682.1A EP11738682A EP2592937A1 EP 2592937 A1 EP2592937 A1 EP 2592937A1 EP 11738682 A EP11738682 A EP 11738682A EP 2592937 A1 EP2592937 A1 EP 2592937A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- whey
- cell wall
- feed
- concentrated mixture
- wall fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000001035 drying Methods 0.000 title abstract description 8
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 91
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 90
- 239000005862 Whey Substances 0.000 claims abstract description 89
- 239000012634 fragment Substances 0.000 claims abstract description 77
- 239000000203 mixture Substances 0.000 claims abstract description 74
- 210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 32
- 239000000047 product Substances 0.000 claims abstract description 32
- 239000013066 combination product Substances 0.000 claims abstract description 25
- 229940127555 combination product Drugs 0.000 claims abstract description 25
- 235000013305 food Nutrition 0.000 claims abstract description 19
- 210000005253 yeast cell Anatomy 0.000 claims description 40
- 238000002360 preparation method Methods 0.000 claims description 34
- 235000013336 milk Nutrition 0.000 claims description 19
- 239000008267 milk Substances 0.000 claims description 19
- 210000004080 milk Anatomy 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 17
- 210000002421 cell wall Anatomy 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 241001465754 Metazoa Species 0.000 claims description 16
- 239000012466 permeate Substances 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 13
- 238000001704 evaporation Methods 0.000 claims description 12
- 230000008020 evaporation Effects 0.000 claims description 11
- 230000000366 juvenile effect Effects 0.000 claims description 11
- 229920000057 Mannan Polymers 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 6
- 241000235070 Saccharomyces Species 0.000 claims description 5
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 4
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 238000010549 co-Evaporation Methods 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000000725 suspension Substances 0.000 description 8
- 244000309466 calf Species 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 208000035404 Autolysis Diseases 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 206010057248 Cell death Diseases 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000028043 self proteolysis Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102100024023 Histone PARylation factor 1 Human genes 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000283903 Ovis aries Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- -1 as described above Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011868 grain product Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 108010005335 mannoproteins Proteins 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000004466 pelleted feed Substances 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 108010027322 single cell proteins Proteins 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000011552 falling film Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C1/00—Concentration, evaporation or drying
- A23C1/12—Concentration by evaporation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a method for co-evaporating a eukaryotic cell wall fragment preparation and whey and/or whey derived products. It is also concerned with an intermediate concentrated mixture as well as a substantially dry combination product of these two components, as well as their use in feed or food compositions, for example milk replacers for feeding juvenile animals. Background
- Whey is the liquid remaining after milk has been curdled and strained. It is a byproduct of the manufacture of cheese or casein and has several commercial uses. Liquid whey contains lactose, vitamins, protein and minerals along with traces of fat. It can be processed into several streams to be used by other industries. It can be dried to obtain whey powder, it can be crystallized to separate the whey into lactose and delactosed whey, and it may be ultrafiltrated into whey protein concentate and permeate. The permeate may be subjected to crystallization to obtain lactose and delactosed permeate.
- Cheese whey contains more than 93% of water. In addition, it is comprised of about 5% lactose and about 0.8% protein.
- Eukaryotic cell wall fragments particularly those derived from yeast of the genus
- Saccharomyces are used as a prebiotic additive to animal feed.
- the yeast cell wall comprises 35% to 40% of the yeast cell. It is largely composed of mannans and ⁇ -glucans. Mannan is a non-digestible protein carbohydrate, and is considered a prebiotic. It has been shown that ⁇ -glucans interact with the immune system to increase its reaction capabilities.
- Yeast cell walls are a component part of animal feeds, and have also been recognized for their ability to protect and foster juvenile animals, encouraging their inclusion in formulated commercial milk replacers.
- the commercially available yeast cell wall products e.g., Saf- Mannan or Bio-Mos, are available as powders.
- yeast cell wall fragments can be dried by means of evaporation to about 17% dry matter.
- the liquid comprising the yeast cell wall fragments becomes too viscous to pass through an industrial scale evaporator.
- whey and whey-derived products are difficult to dry.
- whey or whey derived products can be concentrated to about 40% dry matter. Higher percentages may be obtained using a thermal vapor recompression system.
- EP 0 035 062 describes the preparation of a concentrate of yeast cells and byproducts of, among others, the milk industry.
- a yeast fluid is evaporated, with or without a solution or suspension of by-products to 16 to 50% dry matter.
- raw materials are mixed in to increase the concentration to 35-60% dry matter.
- the mixture is dried to over 80% dry matter content.
- GB 1 51 1 975 is concerned with a method of utilizing whey for the production of foodstuffs and animal feeds.
- Whey is mixed with a cereal product and the cereal product is hydrolyzed to sugars in the whey itself.
- the sugar-containing whey is then subjected to fermentation with yeast to produce single cell proteins. After fermentation, the single cell proteins may be evaporated and dried.
- DE 26 43 093 deals with animal feedstuffs in pressed form based on solid, fibrous, agricultural by-products and non-fibrous additives.
- GB 1 562 567 relates to a process for the production of a solid water dispersible lipid enriched single cell microbial protein composition by emulsifying the single cell microbial protein.
- Whey solids and yeast solids in the form of whole cells may be used in the composition.
- yeast cell wall fragments Compared to a suspension of whole yeast cells of the same percentage dry matter, a suspension of yeast cell wall fragments is much more viscous. Also, yeast cell wall fragments are much smaller compared to whole yeast cells. Preparations comprising yeast cell wall fragments retain considerably more water than do preparations comprising whole yeast cells. Additionally, in whole yeast cells the surface consists of the external side of the cell wall which consists mainly of mannoproteins.
- yeast cell wall fragments In yeast cell wall fragments, several surfaces are exposed externally: the inner layer of the cell wall consisting of ⁇ -1,3- and ⁇ - 1 ,6-glucans complexed with chitine and/or the cell membrane composed of a phospholipid bilayer, sterols, and optionally proteins, as well as the external side of the cell wall which consists mainly of mannoproteins.
- a yeast cell fragment preparation has properties that are very different from whole yeast cells.
- the present inventor has now surprisingly found that co-evaporation of whey or whey-derived products and eukaryotic cell wall fragment preparations, such as yeast cell wall fragment preparations, improves water removal of both products. Evaporation efficiency was strongly enhanced. Since concentrating liquid streams by means of evaporation is about ten times cheaper than drying by means of spray-drying, any water that can be removed using evaporation provides a considerable economic benefit.
- the present invention provides an improved process for drying two components of, for example, animal feed or milk replacers for juvenile mammals.
- whey or whey-derived products and a eukaryotic (preferably yeast) cell wall fragment preparation in a first step, considerably more water can be evaporated than is the case for each of the separate components.
- the invention provides a method for preparing a concentrated mixture comprising a eukaryotic cell wall fragment preparation and whey and/or whey-derived products, said method comprising the steps of: i) mixing a first liquid comprising said a eukaryotic cell wall fragment preparation and whey and/or a whey derived product to obtain a liquid mixture, and ii) subjecting said liquid mixture to evaporation to obtain a concentrated mixture.
- the method may further comprise the step of spray-drying said concentrated mixture to obtain a combination product comprising a eukaryotic cell wall fragment preparation and solids derived from whey and/or whey-derived products.
- the concentrated mixture may comprise about 33 to about 60% dry matter.
- the combination product comprises less than about 10% (w/w) water.
- the whey and/or whey-derived products may be selected from the group consisting of sweet or sour whey, sweet or sour whey permeate, delactosed whey, and delactosed whey permeate.
- the eukaryotic cell wall fragment preparation comprise yeast cell wall fragments, such as a yeast cell wall fragment preparation, preferably of yeasts of the genus Saccharomyces, preferably belonging to the species Saccharomyces cerevisiae.
- the present invention is concerned with a concentrated mixture obtainable by the method of the invention.
- the present invention is directed to a combination product obtainable by the method of the invention.
- the present invention is directed to a feed or food composition
- a feed or food composition comprising a concentrated mixture of the present invention or a combination product of the present invention.
- Such feed or food composition may be a milk replacer for juvenile animals such as calves, lambs, piglets, and the like.
- Such composition may also be used as a compound in young animal feed, either as a meal, crumble or in pelleted form.
- the present invention provides a method for preparing a concentrated mixture comprising a eukaryotic cell wall fragment preparation and whey and/or a whey-derived product, said method comprising the steps of: i) mixing a first liquid comprising said eukaryotic cell wall fragment preparation and whey and/or a whey-derived product to obtain a liquid mixture, and ii) subjecting said liquid mixture to evaporation to obtain a concentrated mixture.
- a concentrated mixture comprising a eukaryotic cell wall fragment preparation and whey and/or a whey-derived product refers to a mixture that is more concentrated than a mixture that could be obtained by simply mixing the first liquid comprising a eukaryotic cell wall fragment preparation and whey and/or whey-derived products.
- a eukaryotic cell wall fragment preparation cannot be dried by evaporation beyond about 17% dry matter
- whey or whey derived products cannot be dried by evaporation beyond about 60% dry matter.
- the concentrated mixture preferably comprises about 34 to about 60% dry matter, more preferably about 35 to about 60% dry matter, yet more preferably about 40 to about 60% dry matter.
- a eukaryotic cell wall fragment preparation refers to a preparation comprising at least 60%, such as at least 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, or 100% of eukaryotic cell wall fragments.
- eukaryotic cell wall fragments in the context of the present invention refers to the insoluble fraction of eukaryotic cells which is obtained after autolysis or enzymatic hydrolysis, mainly by proteases, of whole eukaryotic cells, leading to the solubilization of at least 50%, and preferably of at least 60% by mass of the dry matter content of the whole eukaryotic cells and preserving the structural polysaccharides of the cell wall.
- a eukaryotic cell wall fragment preparation of the present invention comprises less than about 40%, such as less than about 35%, 30%, 25%, 20%, 15%, 10%, 5%, 4%, 3%, 2%, or 1 % intact (or whole) eukaryotic cells.
- the eukaryotic cell wall fragments may be selected from animal cell wall fragments, plant cell wall fragments, fungal cell wall fragments, and yeast cell wall fragments. It is preferred that the eukaryotic cell wall fragments comprise or consist of yeast cell wall fragments.
- the yeast cell wall fragments of the invention comprise or consist of cell wall fragments of yeasts of the genus Saccharomyces, preferably belonging to the species Saccharomyces cerevisiae.
- Eukaryotic cell wall fragments may be produced by any method known in the art, e.g., as described in US 6,387,420.
- the eukaryotic organism may be grown following common techniques used in food/feed-related fermentations.
- microorganisms such as fungus or yeast
- any of a number of common sugar-containing media such as diluted molasses, may be used to provide a source for growth of the yeasts.
- the biomass may then be separated and washed by centrifugation to yield a yeast cream. Following separation, the microorganism is lysed. Any of a number of methods common in the art may be utilized to lyse the microorganisms, including autolysis and hydrolysis.
- a protease such as papain or any of a number of alkaline or neutral proteases may be added during the lysis phase to accelerate solubilisation of proteins and prevent agglutination of intracellular components.
- the resultant cell wall extract may be washed several times to remove intracellular components and concentrate the extract.
- a eukaryotic cell wall fragment preparation may comprise cell wall fragments of one eukaryotic organism, or cell wall fragments of two or more different eukaryotic organisms may be employed.
- at least one of the two or more eukaryotic organisms is yeast, preferably of the genus Saccharomyces, preferably belonging to the species Saccharomyces cerevisiae.
- cell wall fragments of plants comprising mannose, mannobiose, oligosaccharides and/or mannans are also included.
- the whey and/or whey-derived products may be selected from the group consisting of sweet or sour whey, sweet or sour whey permeate, delactosed whey, and delactosed whey permeate.
- One of whey or whey-derived products may be used, or they may be mixed prior to combining them with the first liquid comprising the eukaryotic cell wall fragments.
- the first liquid comprising the eukaryotic cell wall fragment preparation and the whey and/or whey-derived product(s) may be mixed in any way known in the art, for example, simply by stirring. They may be mixed in various ratios, for example, about 80 to 40% on dry matter basis solids derived from whey and/or whey-derived products and about 20 to 60% on dry matter basis eukaryotic cell wall fragment preparation. Thus far, best results have been obtained using about 70% on dry matter basis solids derived from whey and/or whey- derived products, and about 30% on dry matter basis eukaryotic cell wall fragment preparation. They may also be homogenized.
- Suitable evaporators include, without limitation, rotary evaporators, falling film evaporators, thin film evaporators, scrapped surface evaporators, forced circulation evaporators, combination evaporators, plate evaporators, and thermal and/or mechanical vapor recompression evaporator.
- suitable operating conditions including temperatures and pressures. Suitable operating conditions depend on the type of evaporator used.
- a mechanical vapor recompression evaporator is used.
- Such evaporator is highly cost- and energy-effective.
- temperatures employed for a 3-stage mechanical vapor recompression evaporator may be temperatures of 64, 59, and 46°C at stages 1 , 2, and 3, respectively.
- the method may further comprise the step of spray-drying said concentrated mixture to obtain a combination product comprising said eukaryotic cell wall fragment preparation and solids derived from whey and/or whey-derived products.
- a suitable spray-drier is a single-stage spray-drier.
- suitable settings include, without limitation, an inlet temperature in the range of about 170 to about 200°C, and an outlet temperature in the range of about 70 to about 100°C.
- the combination product preferably comprises less than about 10% (w/w), preferably less than 8% (w/w), 7% (w/w), 6% (w/w), 5% (w/w), 4% (w/w), 3% (w/w) water.
- the present invention is concerned with a concentrated mixture obtainable by the method of the invention.
- Said concentrated mixture comprises eukaryotic cell wall fragments as described above, and solids derived from whey or whey-derived products as described above, both in suspension.
- the concentrated mixture preferably comprises about 30 to about 60% dry matter, more preferably about 35 to about 60% dry matter, yet more preferably about 40 to about 60% dry matter.
- said concentrated mixture consists essentially of eukaryotic cells wall fragments, such as yeast cell wall fragments, as described above, and solids derived from whey or whey-derived products as described above, and water.
- the concentrated mixture may further be spray-dried to yield a combination product comprising eukaryotic cell wall fragments as described above, and solids derived from (delactosed) whey, or (delactosed) whey permeate, which combination product is substantially free of water.
- the combination product preferably comprises less than about 10% (w/w), preferably less than 8% (w/w), 7% (w/w), 6% (w/w), 5% (w/w), 4% (w/w), 3% (w/w) water.
- the present invention is further directed to such combination product obtainable by the method of the invention.
- said combination product consists essentially of eukaryotic cells wall fragments, such as yeast cell wall fragments, as described above, and solids derived from whey or whey-derived products as described above.
- the concentrated mixture or combination product of the present invention can be used as a food additive or as a feed additive as such.
- the feed additive prepared by the method of the invention can be added to a feed composition or food composition as such, moisturised or dried, and it can be generally treated as desired. It can be used in feed compositions for juvenile animals, e.g., pigs, poultry, calves, as well as for pets such as dogs and cats, horses, especially foals, fish and so on. Preferably, it is used for newly weaned or hatched animals, such as, for example, weaning pigs.
- the concentrated mixture or combination product of the present invention can be added to any commercially available feed compositions for livestock or companion animals or food compositions for human consumption.
- feed composition may be in any form, e.g., powders, meals, crumbles or pelleted feed.
- the present invention is directed to a feed or food composition comprising a concentrated mixture of the present invention or a combination product of the present invention.
- the feed or food composition preferably comprises an amount of about 1 to about 50% (w/w), such as about 2 to 45% (w/w), or about 4 to about 40% (w/w), or about 5 to about 40% (w/w), or about 10, 15, 20, 25 to about 40% (w/w), of the combination product.
- the concentrated mixture of the present invention may have been used in the preparation of the feed or food composition to achieve the desired amounts of combination product of the present invention.
- a content of eukaryotic cell wall fragments yeast cell wall fragments
- such feed or food composition may be a milk replacer for juvenile animals, preferably juvenile mammals, more preferably juvenile mammals, most preferably juvenile mammals excluding humans, such as calves, lambs, piglets, and the like.
- Such milk replacer generally comprises about 15 to about 30% (w/w), preferably about 17 to about 25% (w/w), yet more preferably about 19 to about 23% (w/w) protein, preferably including milk protein, preferably derived from whey, and sometimes also egg proteins, animal plasma proteins, wheat proteins, soy proteins, and the like; about 10 to about 25% (w/w), preferably about 15 to about 20% (w/w), fats and oils such as milk fat, lard, choice white grease, and/or vegetable oils such as soy, palm and coconut oil; and about 25 to about 50% (w/w), preferably about 35 to about 45% (w/w) carbohydrates such as lactose, dextrose, and/or galactose.
- milk replacers further comprise minerals, and vitamins.
- the milk replacer comprises about 1 to about 15% (w/w), about 2 to 13% (w/w), or about 4 to about 1 1 % (w/w), or about 5 to about 10% (w/w), eukaryotic cell wall fragments, preferably yeast cell wall fragments, as above, derived from 1 to about 50% (w/w), such as about 2 to 45% (w/w), or about 4 to about 40% (w/w), or about 5 to about 40% (w/w), or about 10, 15, 20, 25 to about 40% (w/w), of the concentrated mixture comprising the combination product of the present invention.
- the concentrated mixture of the present invention may have been used in the preparation of the feed or food composition to achieve the desired amounts of combination product of the present invention.
- a content of about 10% based on dry matter eukaryotic cell wall fragments is very suitable.
- the feed or food composition of the present invention may further comprise mannose, mannobiose, oligosaccharides, mannans, and/or plant cell wall fragments, said plant cell wall fragments preferably comprising mannose, mannobiose, oligosaccharides, and/or mannans.
- the concentrated mixture is mixed with further liquid components of a food or feed composition, optionally homogenized, for example at a pressure of about 60 to about 160 bar, and subsequently spray-dried together with said further liquid components of a feed or food composition.
- a food or feed composition optionally homogenized, for example at a pressure of about 60 to about 160 bar, and subsequently spray-dried together with said further liquid components of a feed or food composition.
- Percentage (%) dm or “% based on dry matter” as used herein refers to the percentage of dry matter.
- the dry matter also known as dry weight
- the dry matter of a feed/milk replacer composition contains all its constituents excluding water.
- the percentage of dry matter of a single constituent of such feed/milk replacer composition is the mass of such constituent contained in the feed/milk replacer composition divided by the total mass of all constituents excluding water of said feed/milk replacer composition.
- (w/w) is an abbreviation for "by weight,” used to describe the concentration of a substance in a mixture or solution.
- a weight percentage of 2, 2% (w/w) means that the mass of the substance is 2% of the total mass.
- the term “substantially” herein will be understood by the person skilled in the art. In embodiments the adjective substantially may be removed. Where applicable, the term “substantially” may also include embodiments with “entirely”, “completely”, “all”, etc. Where applicable, the term “substantially” may also relate to 90% or higher, such as 95% or higher, especially 99% or higher, even more especially 99.5% or higher, including 100%.
- the term "about” may, where applicable, indicate a deviation of 10% or less, or 5% or less, or 1 % or less, or 0.5% or less, or even 01.% or less, and also in an embodiment no (measureable) deviation.
- small deviations from numerical values may, where applicable, in general be allowed.
- numerical values may, where applicable deviate a 10% or less, or 5% or less, or 1 % or less, or 0.5% or less, or even 0.1 % or less from the given value. To stress this, herein sometimes the word "about” is used before numerical values.
- Example 1 Preparation of co-dried whey permeate and yeast cell wall fragments Whey permeate having a dry matter content on weight basis of about 38% and a liquid suspension comprising yeast cell wall fragments having a dry matter content on weight basis of about 16.1 %, both of which could not be dried any further by means of evaporation, were mixed and co-evaporated in a 3-stage mechanical vapor recompression evaporator (temperature at stages 1-3: 64, 59, and 46°C, respectively). A dry matter content of 37.1 % on weight basis could be yielded.
- the total amount of water that has evaporated by means of the evaporator is 7494 kg water. This could only be achieved by means of co-evaporation.
- the suspension comprising 37.1 % dry matter on weight basis yeast cell wall fragments and permeate solids was spray-dried on a single-stage spray-drier under the following conditions: inlet temperature: 181°C; outlet temperature: 89°C.
- the resultant after spray- drying comprised the yeast cell wall fragments, whey permeate solids, and about 3.6% (w/w) water.
- Example 2 A composition of calf milk replacer for rearing calves
- Fat concentrate 50/50 25% (50% sweet whey and 50% fat)
- Premix for calf milk replacer may constitute, for example, the following ingredients:
- Vitamin A I E 1500000 30000
- Fe Fe(ll)Sulph. mg 5000 100
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Freezing, Cooling And Drying Of Foods (AREA)
- Meat, Egg Or Seafood Products (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11738682.1A EP2592937A1 (en) | 2010-07-16 | 2011-07-18 | Improved drying of components |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36488810P | 2010-07-16 | 2010-07-16 | |
EP10169849 | 2010-07-16 | ||
PCT/EP2011/062213 WO2012007590A1 (en) | 2010-07-16 | 2011-07-18 | Improved drying of components |
EP11738682.1A EP2592937A1 (en) | 2010-07-16 | 2011-07-18 | Improved drying of components |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2592937A1 true EP2592937A1 (en) | 2013-05-22 |
Family
ID=42712502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11738682.1A Withdrawn EP2592937A1 (en) | 2010-07-16 | 2011-07-18 | Improved drying of components |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2592937A1 (pt) |
BR (1) | BR112013000976A2 (pt) |
EA (1) | EA031155B1 (pt) |
WO (1) | WO2012007590A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2658664C2 (ru) * | 2013-03-15 | 2018-06-22 | Марс, Инкорпорейтед | Аэрированное лакомство для домашних животных |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH621925A5 (en) | 1975-07-30 | 1981-03-13 | Mueller Hans Dr Ing Fa | Process for isolating proteins from whey and protein- and starch-containing natural products |
GB1562567A (en) | 1975-08-28 | 1980-03-12 | British Petroleum Co | Animal feedstuffs |
DE2643093C3 (de) | 1976-09-24 | 1980-01-10 | Rudolf 8430 Neumarkt Schanze | Herstellung von Futtermitteln oder Futtermittelzusätzen |
DE3007383A1 (de) | 1980-02-27 | 1981-09-03 | Rudolf 8034 Unterpfaffenhofen Schanze | Verfahren zur herstellung eines konzentrats aus hefefluessigkeit |
US6387420B1 (en) | 1996-12-23 | 2002-05-14 | Juhani Vuorenmaa | Procedure for preparing a food additive, and an additive and its use |
-
2011
- 2011-07-18 EP EP11738682.1A patent/EP2592937A1/en not_active Withdrawn
- 2011-07-18 EA EA201390125A patent/EA031155B1/ru not_active IP Right Cessation
- 2011-07-18 WO PCT/EP2011/062213 patent/WO2012007590A1/en active Application Filing
- 2011-07-18 BR BR112013000976A patent/BR112013000976A2/pt not_active Application Discontinuation
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2012007590A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012007590A1 (en) | 2012-01-19 |
EA031155B1 (ru) | 2018-11-30 |
EA201390125A1 (ru) | 2013-06-28 |
BR112013000976A2 (pt) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103859165A (zh) | 一种饲料用霉菌毒素脱毒剂及其制备方法与应用 | |
TR201808935T4 (tr) | Ruminant diyet takviyesi bileşimleri ve bunların üretim ve kullanım yöntemleri. | |
CA2748979C (en) | Sodium stearoyl-2-lactylate derivatives as an animal feed additive for improving fat utilization efficiency | |
CN102813088A (zh) | 一种断奶仔猪过渡配合饲料及其制备方法 | |
CN104012758A (zh) | 生物发酵饲料及其制备方法 | |
CN108289478A (zh) | 包含精油和溶菌酶的用于水生动物的饲料添加剂 | |
El-Katcha et al. | Effect of Pediococcus spp. Supplementation on Growth Performance, Nutrient Digestibility and Some Blood Serum Biochemical Changes of Fattening Lambs. | |
CN108471782A (zh) | 饲喂动物葡甘露糖蛋白(glucomannoprotein)产品的方法 | |
JPS62104552A (ja) | 飼料組成物 | |
US20210340490A1 (en) | Method for enriching a biomass with proteins | |
El-Katcha et al. | Effect of Garlic Extract Supplementation on Growth Performance, Nutrient Digestibility and Some Blood Serum Biochemical Changes of Fattening Lambs. | |
CN1911068B (zh) | 畜禽幼苗生长促进剂及其制备方法 | |
CN106260677A (zh) | 一种用于宠物犬猫人工合成乳的配方和工艺 | |
US20210051978A1 (en) | Animal Feed from Minimally Dewatered Microalgal Slurry | |
Abdel-Khalek et al. | Growth performance, digestibility coefficients, blood parameters and carcass traits of rabbits fed biologically treated diets | |
KR101600669B1 (ko) | β-글루칸 및 케이퍼를 유효성분으로 포함하는 가금류의 육질 개선용 사료첨가제, 이를 이용한 사료 조성물 및 사육 방법 | |
EP2592937A1 (en) | Improved drying of components | |
CA2655755C (en) | Zygomycetes for fish feed | |
PL90065B1 (en) | Process for the production of a protein-vitamin concentrate by using yeasts from animal or vegetable fats and for its transformation into a product[US3966554A] | |
Braun et al. | Liquid swine feed ingredients: Nutritional quality and contaminants | |
Aleid | Industrial biotechnology: date palm fruit applications | |
Belewu et al. | Cocktail of fungi blend on Jatropha curcas kernel cake: effect on feed intake and blood parameters of goat | |
JP2021153543A (ja) | フレッシュ廃液を利用した飼料 | |
EP0946108A1 (en) | A method for producing food additive, food additive and the use of it | |
Hafez et al. | Effect of algae supplementation on growth performance and carcass characteristics of growing male lambs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130207 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20170116 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23L 33/19 20160101ALI20190618BHEP Ipc: A23C 21/08 20060101ALI20190618BHEP Ipc: A23K 20/147 20160101ALI20190618BHEP Ipc: A23K 50/60 20160101ALI20190618BHEP Ipc: A23L 33/14 20160101ALI20190618BHEP Ipc: A23K 10/16 20160101ALI20190618BHEP Ipc: A23C 1/12 20060101AFI20190618BHEP Ipc: A23K 20/163 20160101ALI20190618BHEP |
|
INTG | Intention to grant announced |
Effective date: 20190709 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20191120 |